Search

everythinglearnresearchcommunity

for

Search:↓

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

EDA2R gene linked to hair loss.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

DHT enhances androgen receptor activity more than testosterone, and MAGE-11 influences this activity through specific interactions.

Aralia continentalis root extract may help with hair growth.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Cedar and castor oils with high frequency can help hair growth in androgenetic alopecia.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Deucravacitinib helped a man regrow hair significantly.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

A reliable method was developed to measure aristolochic acid-I in rat blood.